Xofluza

Baloxavir marboxil (BXM), sold under the brand name Xofluza, is an antiviral medication for treatment of influenza A and influenza B flu.[2] It was approved for medical use both in Japan and in the United States in 2018,[4][5][6] and is taken as a single dose by mouth.[2] It may reduce the duration of flu symptoms by about a day, but is prone to selection of resistant mutants that render it ineffectual.[7&... [wikipedia]